These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1497314)

  • 1. Recombinant toxins as novel therapeutic agents.
    Pastan I; Chaudhary V; FitzGerald DJ
    Annu Rev Biochem; 1992; 61():331-54. PubMed ID: 1497314
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotoxins and recombinant toxins for cancer treatment.
    Pai LH; Pastan I
    Important Adv Oncol; 1994; ():3-19. PubMed ID: 8206493
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo studies with chimeric toxins. Interleukin-2 fusion toxins as immunosuppressive agents.
    Shapiro ME; Kirkman RL; Kelley VR; Bacha P; Nichols JC; Strom TB
    Targeted Diagn Ther; 1992; 7():383-93. PubMed ID: 1633300
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeted toxin therapy for the treatment of cancer.
    FitzGerald D; Pastan I
    J Natl Cancer Inst; 1989 Oct; 81(19):1455-63. PubMed ID: 2550658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted toxins in brain tumor therapy.
    Li YM; Hall WA
    Toxins (Basel); 2010 Nov; 2(11):2645-62. PubMed ID: 22069569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials of targeted toxins.
    Frankel AE; Tagge EP; Willingham MC
    Semin Cancer Biol; 1995 Oct; 6(5):307-17. PubMed ID: 8562908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant toxins for the treatment of cancer.
    Kreitman RJ
    Curr Opin Mol Ther; 2003 Feb; 5(1):44-51. PubMed ID: 12669470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant toxins.
    Kreitman RJ; Pastan I
    Adv Pharmacol; 1994; 28():193-219. PubMed ID: 8080817
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant fusion toxins--a new class of targeted biologic therapeutics.
    Woodworth TG; Nichols JC
    Cancer Treat Res; 1993; 68():145-60. PubMed ID: 8105849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 toxin holds promise as treatment for HIV infection.
    Am Fam Physician; 1988 Nov; 38(5):355-6. PubMed ID: 3263790
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant immunotoxins for treating cancer.
    FitzGerald DJ; Kreitman R; Wilson W; Squires D; Pastan I
    Int J Med Microbiol; 2004 Apr; 293(7-8):577-82. PubMed ID: 15149034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic activities of recombinant immunotoxins composed of Pseudomonas toxin or diphtheria toxin toward lymphocytes from patients with adult T-cell leukemia.
    Kreitman RJ; Chaudhary VK; Waldmann TA; Hanchard B; Cranston B; FitzGerald DJ; Pastan I
    Leukemia; 1993 Apr; 7(4):553-62. PubMed ID: 8464234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted therapy of cancer using diphtheria toxin-derived immunotoxins.
    Potala S; Sahoo SK; Verma RS
    Drug Discov Today; 2008 Sep; 13(17-18):807-15. PubMed ID: 18678276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide toxins directed at the matrix dissolution systems of cancer cells.
    Frankel AE; Bugge TH; Liu S; Vallera DA; Leppla SH
    Protein Pept Lett; 2002 Feb; 9(1):1-14. PubMed ID: 12141918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotoxins: is there a clinical value?
    Gottstein C; Winkler U; Bohlen H; Diehl V; Engert A
    Ann Oncol; 1994; 5 Suppl 1():97-103. PubMed ID: 7826425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic activities of conjugates of human transferrin and A subunits of plant toxins both in vitro and in vivo.
    Tonevitsky AG; Demina IA; Agapov II; Fattakhova GV; Popova EN; Moysenovich MM; Komolov IS; Khalanskii AS; Kirpichnikov MP
    Dokl Biochem; 2000; 374(1-6):210-3. PubMed ID: 11109967
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recombinant immunotoxins and chimeric toxins for targeted therapy in oncology].
    Chiron MF
    Bull Cancer; 1997 Dec; 84(12):1135-40. PubMed ID: 9587366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies as carriers of toxins.
    Uhr JW; Fulton RJ; Till MA; May RD; Vitetta ES
    Prog Clin Biol Res; 1989; 288():403-12. PubMed ID: 2785694
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxin-based therapeutic approaches.
    Shapira A; Benhar I
    Toxins (Basel); 2010 Nov; 2(11):2519-83. PubMed ID: 22069564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconsidering targeted toxins to eliminate HIV infection: you gotta have HAART.
    Berger EA; Moss B; Pastan I
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11511-3. PubMed ID: 9751696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.